Kurt A. Gustafson
2010 - Halozyme Therapeutics
Compensation breakdown
Non-Equity Incentive Plan | $78,875 |
---|---|
Option Awards | $93,260 |
Salary | $310,000 |
Other | $7,662 |
Total | $489,797 |
Gustafson received $310K in salary, accounting for 63% of the total pay in 2010.
Gustafson also received $78.9K in non-equity incentive plan, $93.3K in option awards and $7.7K in other compensation.
Rankings
In 2010, Kurt A. Gustafson's compensation ranked 7,781st out of 10,439 executives tracked by ExecPay. In other words, Gustafson earned more than 25.5% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 7,781 | 26th |
Manufacturing | 2,891 | 25th |
Chemicals And Allied Products | 693 | 25th |
Drugs | 480 | 30th |
Biological Products, Except Diagnostic Substances | 96 | 35th |
Gustafson's colleagues
We found seven more compensation records of executives who worked with Kurt A. Gustafson at Halozyme Therapeutics in 2010.
2010
Jonathan Lim
Halozyme Therapeutics
Chief Executive Officer
2010
Gregory Frost
Halozyme Therapeutics
Chief Executive Officer
2010
Robert Little
Halozyme Therapeutics
Vice President and Chief Commercial Officer
2010
Jonathan Leff
Halozyme Therapeutics
Chief Medical Officer
2010
William Fallon
Halozyme Therapeutics
Vice President, Manufacturing & Operations
2010
H Shepard
Halozyme Therapeutics
Chief Scientific Officer
2010
Michael LaBarre
Halozyme Therapeutics
Vice President, Product Development
News
April 26, 2024
May 1, 2023
April 27, 2022
April 22, 2020
April 23, 2019